UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Update on the Management of Brain Metastasis

Neurotherapeutics, 2022-10, Vol.19 (6), p.1772-1781

2022

Volltextzugriff (PDF)

DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets

Cancers, 2023-02, Vol.15 (4), p.1342

2023

Volltextzugriff (PDF)

First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases

Cancers, 2023-04, Vol.15 (8), p.2382

2023

Volltextzugriff (PDF)

Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study

Cancers, 2023-06, Vol.15 (11), p.3015

2023

Volltextzugriff (PDF)

Endoglin inhibitor TRC105 with or without bevacizumab for bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase II trial

Communications medicine, 2023-09, Vol.3 (1), p.120-120, Article 120

2023

Volltextzugriff (PDF)

Key Clinical Principles in the Management of Glioblastoma

JCO oncology practice, 2023-04, Vol.19 (4), p.180-189

2023

Volltextzugriff (PDF)

Authorship diversity in global evidence synthesis in urology: 1998–2022 analysis of Cochrane reviews

BJU international, 2023-07, Vol.132 (1), p.34-36

2023

Volltextzugriff (PDF)

Impact of tissue-agnostic approvals on management of primary brain tumors

Trends in Cancer, 2024-03, Vol.10 (3), p.256-274

2024

Volltextzugriff (PDF)

Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies

Current oncology reports, 2024, Vol.26 (1), p.80-89

2024

Volltextzugriff (PDF)

Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients

Journal of neuro-oncology, 2023-10, Vol.165 (1), p.63-77

2023

Volltextzugriff (PDF)

A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR)

Cell reports. Medicine, 2024-07, Vol.5 (7), p.101630, Article 101630

2024

Volltextzugriff (PDF)

S2385 The Great Mimicker: Esophageal Sarcoidosis Masquerading as Malignancy

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e1597-e1597

2022

Volltextzugriff (PDF)

Perception of Bariatric Surgery and Endoscopic Bariatric Therapies Among Primary Care Physicians

Obesity surgery, 2022-10, Vol.32 (10), p.3384-3389

2022

Volltextzugriff (PDF)

CLO24-084: Myeloid Sarcoma in a Patient With Marfan Syndrome

Journal of the National Comprehensive Cancer Network, 2024-04, Vol.22 (2.5)

2024

Volltextzugriff (PDF)

Fibrolamellar hepatocellular carcinoma (FL-HCC) epidemiology, survival characteristics, and outcomes: Surveillance, epidemiology, and end results database (SEER) study

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e16213-e16213

2024

Volltextzugriff (PDF)

Bispecific Antibodies in Lung Cancer: A State-of-the-Art Review

Pharmaceuticals (Basel, Switzerland), 2023-10, Vol.16 (10), p.1461

2023

Volltextzugriff (PDF)

Metabolic Syndrome Among Patients with Myelodysplastic Syndrome: A Population Analysis

Blood, 2023-11, Vol.142 (Supplement 1), p.3805-3805

2023

Volltextzugriff (PDF)

Racial Disparity in Hematopoietic Stem Cell Transplant Clinical Trial Recruitment

Blood, 2023-11, Vol.142 (Supplement 1), p.3694-3694

2023

Volltextzugriff (PDF)

1244: CAN ADMINISTRATION OF HIGH-DOSE HYDROXOCOBALAMIN IMPROVE OUTCOMES IN REFRACTORY SEPTIC SHOCK?

Critical care medicine, 2023-01, Vol.51 (1), p.621-621

2023

Volltextzugriff (PDF)

Trilaciclib use for prevention of hematological adverse events in chemotherapy: A meta-analysis of real-world studies and clinical trials

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e24130-e24130

2024

Volltextzugriff (PDF)

A comprehensive analysis of patient demographics and disparities in contemporary oncology clinical trials (2022-2023)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e13748-e13748

2024

Volltextzugriff (PDF)

Outcomes and Trends of Endoscopic Bariatric Therapies (EBT) Among Minority Populations

Obesity surgery, 2023-02, Vol.33 (2), p.513-522

2023

Volltextzugriff (PDF)

Analysis of a national database to evaluate place-of-death preferences among patients with bladder cancer in the United States of America from 2003 to 2020

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.580-580

2024

Volltextzugriff (PDF)

Trends and disparities in hospice care utilization in testicular cancer in the United States of America from 2003 to 2020: Analysis of CDC WONDER database

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.504-504

2024

Volltextzugriff (PDF)

Quality assessment of information on chimeric antigen receptor T-cell therapy on YouTube: An analysis

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e13633-e13633

2023

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Englisch
(92)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Update on the Management of Brain Metastasis

DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets

First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases

Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study

Endoglin inhibitor TRC105 with or without bevacizumab for bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase II trial

Key Clinical Principles in the Management of Glioblastoma

Authorship diversity in global evidence synthesis in urology: 1998–2022 analysis of Cochrane reviews

Impact of tissue-agnostic approvals on management of primary brain tumors

Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies

Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patients

A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR)

S2385 The Great Mimicker: Esophageal Sarcoidosis Masquerading as Malignancy

Perception of Bariatric Surgery and Endoscopic Bariatric Therapies Among Primary Care Physicians

CLO24-084: Myeloid Sarcoma in a Patient With Marfan Syndrome

Fibrolamellar hepatocellular carcinoma (FL-HCC) epidemiology, survival characteristics, and outcomes: Surveillance, epidemiology, and end results database (SEER) study

Bispecific Antibodies in Lung Cancer: A State-of-the-Art Review

Metabolic Syndrome Among Patients with Myelodysplastic Syndrome: A Population Analysis

Racial Disparity in Hematopoietic Stem Cell Transplant Clinical Trial Recruitment

1244: CAN ADMINISTRATION OF HIGH-DOSE HYDROXOCOBALAMIN IMPROVE OUTCOMES IN REFRACTORY SEPTIC SHOCK?

Trilaciclib use for prevention of hematological adverse events in chemotherapy: A meta-analysis of real-world studies and clinical trials

A comprehensive analysis of patient demographics and disparities in contemporary oncology clinical trials (2022-2023)

Outcomes and Trends of Endoscopic Bariatric Therapies (EBT) Among Minority Populations

Analysis of a national database to evaluate place-of-death preferences among patients with bladder cancer in the United States of America from 2003 to 2020

Trends and disparities in hospice care utilization in testicular cancer in the United States of America from 2003 to 2020: Analysis of CDC WONDER database

Quality assessment of information on chimeric antigen receptor T-cell therapy on YouTube: An analysis

Suchergebnisse filtern